JPH10109977A - Production of optically active pyridazinone derivative - Google Patents

Production of optically active pyridazinone derivative

Info

Publication number
JPH10109977A
JPH10109977A JP28295396A JP28295396A JPH10109977A JP H10109977 A JPH10109977 A JP H10109977A JP 28295396 A JP28295396 A JP 28295396A JP 28295396 A JP28295396 A JP 28295396A JP H10109977 A JPH10109977 A JP H10109977A
Authority
JP
Japan
Prior art keywords
pyridazinone
formula
configuration
optically active
tartaric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP28295396A
Other languages
Japanese (ja)
Inventor
Tetsuya Kato
哲也 加藤
Minoru Kaeriyama
稔 帰山
Michiyo Osawa
通世 大沢
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Soda Co Ltd
Original Assignee
Nippon Soda Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Soda Co Ltd filed Critical Nippon Soda Co Ltd
Priority to JP28295396A priority Critical patent/JPH10109977A/en
Publication of JPH10109977A publication Critical patent/JPH10109977A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain the subject compound useful as intermediate for medicines by optical resolution of the racemic form of pyridazinone. SOLUTION: This optically active pyridazinone having R- or S-configuration of formula II is obtained by optical resolution of the racemic form of pyridazinone shown by formula I by the use of L- or D-tartaric acid as a resolution agent in a mixed solvent (e.g. 1-propanol/ethyl acetate). In this case, the molar ratio of the L- or D-tartaric acid to the compound of formula I is 0.3-1.8. Besides, a system containing an excess of the unnecessary compound of formula II with R- or S-configuration or its tartrate is treated with an acid or base to enable recovering the racemic form of formula I. The above method affords the objective compound of formula II in high optical purity at low cost, considerably reduces the amount of the solvent to be used, and shortens the production time for the amied compound.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明が属する技術分野】本発明は式[II]The present invention relates to a compound of the formula [II]

【化3】 で表されるR−配置またはS−配置を有する光学活性ピ
リダジノンの工業的に有用な製造方法に関する。式[I
I]で表される光学活性ピリダジノンは、例えば、WO
96/15117に記載されている優れた血小板凝集抑
制作用を有する式[III ]
Embedded image An industrially useful method for producing an optically active pyridazinone having an R-configuration or an S-configuration represented by The formula [I
The optically active pyridazinone represented by I] is, for example, WO
Formula [III] having an excellent platelet aggregation inhibitory action described in US Pat.

【化4】 で表される化合物の中間体として有用である。Embedded image It is useful as an intermediate of the compound represented by

【0002】[0002]

【従来の技術】光学活性ピリダジノンの製造法としては
一般的に光学異性体分離用カラムで分離する方法(例え
ばEP208518など)が知られているが、工業的規
模には適用できない。特開平3−163050に4−
(4−アミノフェニル)−3−メチル−4−オキシブチ
ル酸から不斉還元法により合成する方法が報告されてい
るが、高温、高圧下の反応なため特殊な設備が必要とな
る。また特表平6−504275に2−プロパノール溶
媒中で、L−またはD−酒石酸を2〜3当量使用し光学
分割する方法が記載されている。しかし、この方法は光
学純度が10%ee程度のピリダジノン・酒石酸塩を得
るために大量の溶媒を必要とするうえ、熟成のための時
間を多く取らねばならず、また分割効率も低い。溶媒量
を低減あるいは製造時間を短縮すると、得られる塩の光
学純度は著しく低下し、やはり工業生産には不向きであ
る。
2. Description of the Related Art As a method for producing an optically active pyridazinone, a method of separating it with an optical isomer separation column (for example, EP208518) is generally known, but cannot be applied on an industrial scale. JP-A-3-163050
Although a method of synthesizing from (4-aminophenyl) -3-methyl-4-oxybutyric acid by an asymmetric reduction method has been reported, special equipment is required because of the reaction under high temperature and high pressure. JP-T-Hei 6-504275 describes a method for optical resolution using L- or D-tartaric acid in an amount of 2-3 equivalents in a 2-propanol solvent. However, this method requires a large amount of a solvent in order to obtain a pyridazinone / tartrate having an optical purity of about 10% ee, requires much time for ripening, and has a low resolution. When the amount of the solvent is reduced or the production time is shortened, the optical purity of the obtained salt is remarkably reduced, which is unsuitable for industrial production.

【0003】[0003]

【発明が解決しようとする課題】本発明は、式[II]で
表される光学活性ピリダジノンを工業生産に有利な方法
によって製造することを目的としている。
An object of the present invention is to produce an optically active pyridazinone represented by the formula [II] by a method advantageous for industrial production.

【0004】[0004]

【課題を解決するための手段】本発明は(1)式[I]According to the present invention, there is provided (1) the formula [I]

【化5】 で表されるピリダジノンのラセミ体(以下、(±)−ピ
リダジノンという)をL−またはD−酒石酸を分割剤と
して、低級アルコールとエステル類との混合溶媒中で分
割することを特徴とする式[II]で表されるR−配置ま
たはS−配置を有する光学活性ピリダジノンの製造方
法、(2)(±)−ピリダジノンを有機溶媒中、L−ま
たはD−酒石酸を1モルに対し0.3〜1.8モル使用
し、分割することを特徴とするR−配置またはS−配置
を有する光学活性ピリダジノンの製造方法及び(3)上
記(1)または(2)により分割され、不要のR−配置
またはS−配置を有する光学活性ピリダジノンまたはそ
の酒石酸塩が過剰に含まれる系を酸または塩基で処理す
ることによる(±)−ピリダジノンの回収方法である。
Embedded image A racemate of pyridazinone (hereinafter referred to as (±) -pyridazinone) represented by the formula: wherein L- or D-tartaric acid is used as a resolving agent in a mixed solvent of a lower alcohol and an ester; II] A method for producing an optically active pyridazinone having an R-configuration or an S-configuration represented by (2): (2) using (±) -pyridazinone in an organic solvent, L- or D-tartaric acid in an amount of 0.3 to 1 mol. A method for producing an optically active pyridazinone having an R-configuration or an S-configuration characterized by using 1.8 moles and resolving, and (3) an unnecessary R-configuration separated by the above (1) or (2) Or a method for recovering (±) -pyridazinone by treating a system containing an optically active pyridazinone or its tartrate salt having an S-configuration in excess with an acid or a base.

【0005】[0005]

【発明の実施の形態】前記式[II]の化合物は下記式BEST MODE FOR CARRYING OUT THE INVENTION The compound of the formula [II] is represented by the following formula:

【化6】 で表されるR体またはS体のいずれかであるが、前記式
[III ]の中間体として用いる場合は前者のR体が使用
される。光学分割剤として使用するL−またはD−酒石
酸は、前記式[II]のR体を得る場合にはL−酒石酸が
好適である。光学分割は、(±)−ピリダジノンおよび
L−またはD−酒石酸に低級アルコールとエステル類と
の混合溶媒を添加するか、または低級アルコールとエス
テル類との混合溶媒に(±)−ピリダジノンおよびL−
またはD−酒石酸を添加後、両者が溶解するまで昇温し
その温度で数分から数時間加熱する。その後冷却し、必
要に応じて光学活性ピリダジノンの酒石酸塩を接種し、
撹拌した後に析出した光学活性ピリダジノンの酒石酸塩
を濾別する。得られた塩の結晶は、実用可能な高い光学
純度を有し、再結晶等の手段によってさらに光学純度を
上げることができる。このようにして得られた光学活性
体の塩は炭酸カリウム、炭酸ナトリウム、水酸化ナトリ
ウムなどのアルカリ水溶液によりフリー化した後、再結
晶などの手法によって光学純度の高いRまたはSピリダ
ジノンを製造することができる。
Embedded image In the case where it is used as an intermediate of the formula [III], the former R-form is used. The L- or D-tartaric acid used as the optical resolving agent is preferably L-tartaric acid when the R-form of the formula [II] is obtained. Optical resolution can be performed by adding a mixed solvent of a lower alcohol and an ester to (±) -pyridazinone and L- or D-tartaric acid, or by adding a mixed solvent of a lower alcohol and an ester to (±) -pyridazinone and L-tartaric acid.
Alternatively, after adding D-tartaric acid, the temperature is raised until both are dissolved, and the mixture is heated at that temperature for several minutes to several hours. After cooling, inoculate an optically active pyridazinone tartrate as needed,
After stirring, the precipitated tartrate salt of the optically active pyridazinone precipitated is filtered off. The obtained salt crystals have a practically high optical purity, and the optical purity can be further increased by means such as recrystallization. The salt of the optically active substance thus obtained is made free with an aqueous alkali solution such as potassium carbonate, sodium carbonate or sodium hydroxide, and then R or S pyridazinone with high optical purity is produced by a technique such as recrystallization. Can be.

【0006】酒石酸の量は、(±)−ピリダジノンに対
して2モル以上使用しても低級アルコール等の単独溶媒
中で分割するよりは好結果が得られるが、好ましくは
0.3〜1.8モル、特に好ましくは1.0〜1.5モ
ルである。ここで用いる低級アルコール/エステル類の
混合溶媒の低級アルコール類としてはメタノール、エタ
ノール、1−プロパノール、2−プロパノール、n−ブ
タノール、i−ブタノール等のC1 〜C4 のアルコール
類が好ましいが、1−プロパノール、2−プロパノール
が特に好ましい。エステル類としてはカルボン酸の低級
アルキルエステルが好ましいが、酢酸エチル、酢酸メチ
ルが特に好ましい。混合溶媒の溶媒量としては使用する
溶媒種、混合比によって異なるが、(±)−ピリダジノ
ンと酒石酸の塩が加熱還流下、溶解できる量が好まし
い。低級アルコール/エステル類の混合比は用いる溶媒
の種類によって異なるが、通常10/90〜90/1
0、好ましくは30/70〜70/30である。また、
混合溶媒にかえ、1−プロパノール、2−プロパノール
等の低級アルコール等の単独溶媒でも酒石酸の量を前記
好ましい範囲に規制することにより、従来法に比べ光学
純度を向上させることができる。
The use of tartaric acid in an amount of 2 mol or more with respect to (±) -pyridazinone can provide better results than resolution in a single solvent such as a lower alcohol, but is preferably 0.3 to 1. The amount is 8 mol, particularly preferably 1.0 to 1.5 mol. As the lower alcohol of the mixed solvent of lower alcohol / ester used here, C 1 to C 4 alcohols such as methanol, ethanol, 1-propanol, 2-propanol, n-butanol and i-butanol are preferable, 1-propanol and 2-propanol are particularly preferred. As the esters, lower alkyl esters of carboxylic acids are preferred, and ethyl acetate and methyl acetate are particularly preferred. The amount of the mixed solvent varies depending on the kind of the solvent used and the mixing ratio, but is preferably an amount capable of dissolving the salt of (±) -pyridazinone and tartaric acid under heating and reflux. The mixing ratio of lower alcohols / esters varies depending on the type of solvent used, but is usually 10/90 to 90/1.
0, preferably 30/70 to 70/30. Also,
By controlling the amount of tartaric acid within the above preferred range even with a single solvent such as a lower alcohol such as 1-propanol or 2-propanol instead of the mixed solvent, the optical purity can be improved as compared with the conventional method.

【0007】上記操作により分割され不要となった光学
活性ピリダジノン・酒石酸塩は、次のようにラセミ化、
回収し、再利用することができる。光学分割濾液を濃縮
し、析出した光学活性ピリダジノン・酒石酸塩を濾別す
る。得られた光学活性ピリダジノン・酒石酸塩に水およ
び濃塩酸などの強酸を加え、50℃から還流下で数分か
ら数時間撹拌することによってラセミ化を行う。その
後、水酸化ナトリウム、炭酸カリウム、炭酸ナトリウム
などのアルカリ水溶液によりフリー化し、(±)−ピリ
ダジノンを濾別する。また、上記の光学活性ピリダジノ
ン・酒石酸塩に水および水酸化ナトリウム、水酸化カリ
ウムなどの強塩基を加え、50℃から還流下で数分から
数時間撹拌することによってもラセミ化することができ
る。
The optically active pyridazinone / tartrate salt that has been separated and becomes unnecessary by the above operation is racemized as follows,
Can be collected and reused. The optically resolved filtrate is concentrated, and the precipitated optically active pyridazinone / tartrate salt is filtered off. Racemization is performed by adding water and a strong acid such as concentrated hydrochloric acid to the obtained optically active pyridazinone / tartrate salt and stirring the mixture at 50 ° C. under reflux for several minutes to several hours. Then, it is made free with an aqueous alkali solution such as sodium hydroxide, potassium carbonate, sodium carbonate and the like, and (±) -pyridazinone is separated by filtration. Racemization can also be carried out by adding water and a strong base such as sodium hydroxide or potassium hydroxide to the above-mentioned optically active pyridazinone tartrate and stirring the mixture at 50 ° C. under reflux for several minutes to several hours.

【0008】[0008]

【実施例】以下に実施例をあげて本発明をさらに詳しく
説明する。 実施例1(光学分割) (±)−ピリダジノン4.06g(20.0mmol)
とL−酒石酸3.60g(24.0mmol)に1−プ
ロパノール/酢酸エチル(35/65、体積比)120
ml(6.0l/M)を加え、加熱溶解した。77〜8
1℃で30分撹拌後、ゆっくり冷却した。40℃で結晶
が析出するが、40〜45℃で1時間撹拌後、20〜2
5℃までゆっくり冷却し、さらに1時間撹拌後、結晶を
濾別した。得られた結晶は1−プロパノール/酢酸エチ
ル(35/65)15mlで洗浄後、乾燥しピリダジノ
ン・L−酒石酸塩4.73gを得た。R−ピリダジノン
の光学純度は31.5%e.e.であった。濾液中のS
−ピリダジノンの光学純度は56.1%e.e.で、得
られた結晶の収率は計算により64%と求められた。
The present invention will be described in more detail with reference to the following examples. Example 1 (optical resolution) 4.06 g (20.0 mmol) of (±) -pyridazinone
And 1.60 g (24.0 mmol) of L-tartaric acid and 120 of 1-propanol / ethyl acetate (35/65, volume ratio)
ml (6.0 l / M) was added and dissolved by heating. 77-8
After stirring at 1 ° C. for 30 minutes, the mixture was slowly cooled. Crystals precipitate at 40 ° C, but after stirring at 40-45 ° C for 1 hour, 20-20
After slowly cooling to 5 ° C. and stirring for another 1 hour, the crystals were separated by filtration. The obtained crystals were washed with 15 ml of 1-propanol / ethyl acetate (35/65) and dried to obtain 4.73 g of pyridazinone L-tartrate. The optical purity of R-pyridazinone is 31.5% e. e. Met. S in the filtrate
-The optical purity of pyridazinone is 56.1% e. e. The yield of the obtained crystal was calculated to be 64%.

【0009】実施例2(光学分割) (±)−ピリダジノン90.0g(0.443mol)
とL−酒石酸79.8g(0.531mol)に酢酸エ
チル1730ml、2−プロパノール930mlを加
え、加熱溶解した。75℃で30分撹拌後、ゆっくり冷
却した。52℃で結晶が析出するが、50〜55℃で1
時間撹拌後、20〜25℃までゆっくり冷却し、さらに
1時間撹拌後、結晶を濾別した。得られた結晶は2−プ
ロパノール/酢酸エチル(35/65)200mlで洗
浄後、乾燥しピリダジノン・L−酒石酸塩128.1g
を得た。R−ピリダジノンの光学純度は33.5%e.
e.であった。濾液中のS−ピリダジノンの光学純度は
56.1%e.e.で、得られた結晶の収率は計算によ
り69%と求められた。
Example 2 (optical resolution) 90.0 g (0.443 mol) of (±) -pyridazinone
Then, 1730 ml of ethyl acetate and 930 ml of 2-propanol were added to 79.8 g (0.531 mol) of L-tartaric acid and dissolved by heating. After stirring at 75 ° C. for 30 minutes, the mixture was slowly cooled. Crystals precipitate at 52 ° C, but 1 to 50-55 ° C.
After stirring for 20 hours, the mixture was slowly cooled to 20 to 25 ° C., and further stirred for 1 hour. The obtained crystals were washed with 200 ml of 2-propanol / ethyl acetate (35/65), dried and dried, and pyridazinone / L-tartrate salt (128.1 g) was obtained.
I got The optical purity of R-pyridazinone is 33.5% e.
e. Met. The optical purity of S-pyridazinone in the filtrate was 56.1% e. e. The yield of the obtained crystals was calculated to be 69%.

【0010】実施例3(光学分割) (±)−ピリダジノン1.13g(5.56mmol)
とL−酒石酸1.20g(8.0mmol)にエタノー
ル/酢酸エチル(50/50)25ml(4.5l/
M)を加え、加熱溶解した。68℃で30分撹拌後、ゆ
っくり冷却した。30℃で結晶が析出するが、そのまま
20〜25℃までゆっくり冷却し、さらに1時間撹拌
後、結晶を濾別した。得られた結晶を乾燥しピリダジノ
ン・L−酒石酸塩1.28gを得た。R−ピリダジノン
の光学純度は20.5%e.e.、得られた結晶の収率
は62%であった。
Example 3 (optical resolution) 1.13 g (5.56 mmol) of (±) -pyridazinone
And 1.20 g (8.0 mmol) of L-tartaric acid in 25 ml of ethanol / ethyl acetate (50/50) (4.5 l /
M) was added and dissolved by heating. After stirring at 68 ° C. for 30 minutes, the mixture was slowly cooled. Crystals precipitate at 30 ° C., but the mixture is slowly cooled to 20 to 25 ° C., stirred for 1 hour, and then filtered. The obtained crystals were dried to obtain 1.28 g of pyridazinone L-tartrate. The optical purity of R-pyridazinone is 20.5% e. e. The yield of the obtained crystals was 62%.

【0011】実施例4(光学分割) (±)−ピリダジノン3.00g(14.76mmo
l)とL−酒石酸2.66g(17.71mmol)に
n−ブタノール/酢酸エチル(35/65)102ml
(6.9l/M)を加え、加熱溶解した。86℃で30
分撹拌後、ゆっくり冷却した。51℃で結晶が析出する
が、49〜51℃で1時間撹拌後、そのまま20〜25
℃までゆっくり冷却し、さらに3時間撹拌後、結晶を濾
別した。得られた結晶はn−ブタノール/酢酸エチル
(35/65)10mlで洗浄後、乾燥しピリダジノン
・L−酒石酸塩3.53gを得た。R−ピリダジノンの
光学純度は22.6%e.e.、濾液中のS−ピリダジ
ノンの光学純度は64.8%e.e.で、得られた結晶
の収率は計算により74%と求められた。
Example 4 (optical resolution) 3.00 g of (±) -pyridazinone (14.76 mmol)
l) and 2.66 g (17.71 mmol) of L-tartaric acid in 102 ml of n-butanol / ethyl acetate (35/65)
(6.9 l / M) and dissolved by heating. 30 at 86 ° C
After stirring for minutes, the mixture was slowly cooled. Crystals precipitate at 51 ° C, but after stirring at 49-51 ° C for 1 hour,
After slowly cooling to ℃ and stirring for further 3 hours, the crystals were filtered off. The obtained crystals were washed with 10 ml of n-butanol / ethyl acetate (35/65) and dried to obtain 3.53 g of pyridazinone L-tartrate. The optical purity of R-pyridazinone is 22.6% e. e. The optical purity of S-pyridazinone in the filtrate was 64.8% e. e. The yield of the obtained crystals was calculated to be 74%.

【0012】比較例1(光学分割) (±)−ピリダジノン3.00g(14.76mmo
l)とL−酒石酸4.43g(29.53mmol)に
2−プロパノール89ml(6.0l/mol)を加
え、加熱溶解した。82℃で30分撹拌後、ゆっくり冷
却した。65℃で結晶が析出するが、60〜65℃で1
時間撹拌後、20〜25℃までゆっくり冷却し、さらに
1時間撹拌後、結晶を濾別した。得られた結晶は2−プ
ロパノール9mlで洗浄後、乾燥しピリダジノン・L−
酒石酸塩4.72gを得た。R−ピリダジノンの光学純
度は4.0%e.e.であった。濾液中のS−ピリダジ
ノンの光学純度は82.5%e.e.で、得られた結晶
の収率は計算により95%と求められた。
Comparative Example 1 (optical resolution) (±) -pyridazinone 3.00 g (14.76 mmol)
To 1) and 4.43 g (29.53 mmol) of L-tartaric acid, 89 ml (6.0 l / mol) of 2-propanol was added and dissolved by heating. After stirring at 82 ° C. for 30 minutes, the mixture was slowly cooled. Crystals are precipitated at 65 ° C.
After stirring for 20 hours, the mixture was slowly cooled to 20 to 25 ° C., and further stirred for 1 hour. The resulting crystals were washed with 9 ml of 2-propanol, dried and dried with pyridazinone L-.
4.72 g of tartrate were obtained. The optical purity of R-pyridazinone is 4.0% e. e. Met. The optical purity of S-pyridazinone in the filtrate was 82.5% e. e. The yield of the obtained crystals was calculated to be 95%.

【0013】実施例5(精製) 実施例2で得たピリダジノン・L−酒石酸塩128.1
gに酢酸エチル1210ml、2−プロパノール650
mlを加え、加熱溶解した。75℃で30分撹拌後、ゆ
っくり冷却した。43℃で結晶が析出するが、45℃付
近で1時間撹拌後、20〜25℃までゆっくり冷却し、
さらに1時間撹拌後、結晶を濾別、乾燥した。得られた
結晶は2−プロパノール/酢酸エチル(35/65)1
40mlで洗浄後、乾燥しピリダジノン・L−酒石酸塩
収量84.1gを得た。R−ピリダジノンの光学純度は
63.0%e.e.で、濾液中のS−ピリダジノンの光
学純度は25.5%e.e.であった。得られたピリダ
ジノン・L−酒石酸塩84.1gに水733mlを加え
た。10℃以下に氷冷し、飽和炭酸ナトリウム水溶液を
30分かけて滴下し(温度4〜10℃)、pH8に調整
した。50分撹拌後、結晶を濾別した。得られた結晶は
水100mlで洗浄後、乾燥し、光学純度62.7%
e.e.(R)のピリダジノン37.4gを得た。この
ピリダジノンにジオキサン368mlを加え、100℃
に加熱した。30分撹拌後、ゆっくり冷却した。20〜
25℃で1時間撹拌後、結晶を濾別した。得られた結晶
はジオキサン18mlで洗浄した。洗浄液を含めた濾液
415.2gを濃縮乾固しイソプロピルエーテル230
mlを加え、撹拌後、結晶を濾別した。得られた結晶を
乾燥しR−ピリダジノン23.3gを得た。光学純度9
8.9%e.e.、収率26%(対(±)−ピリダジノ
ン)であった。
Example 5 (Purification) Pyridazinone L-tartrate salt obtained in Example 2 128.1
g in ethyl acetate, 1210 ml, 2-propanol 650
Then, the mixture was heated and dissolved. After stirring at 75 ° C. for 30 minutes, the mixture was slowly cooled. Crystals precipitate at 43 ° C, but after stirring for 1 hour at around 45 ° C, slowly cool to 20 to 25 ° C,
After stirring for an additional hour, the crystals were separated by filtration and dried. The obtained crystals were 2-propanol / ethyl acetate (35/65) 1
After washing with 40 ml, it was dried to obtain 84.1 g of pyridazinone L-tartrate. The optical purity of R-pyridazinone is 63.0% e. e. The optical purity of S-pyridazinone in the filtrate was 25.5% e. e. Met. 733 ml of water was added to 84.1 g of the obtained pyridazinone L-tartrate. The mixture was ice-cooled to 10 ° C. or lower, and a saturated aqueous solution of sodium carbonate was added dropwise over 30 minutes (temperature: 4 to 10 ° C.) to adjust the pH to 8. After stirring for 50 minutes, the crystals were separated by filtration. The obtained crystals were washed with 100 ml of water, dried, and had an optical purity of 62.7%.
e. e. 37.4 g of pyridazinone of (R) were obtained. 368 ml of dioxane is added to this pyridazinone,
Heated. After stirring for 30 minutes, the mixture was slowly cooled. 20 ~
After stirring at 25 ° C. for 1 hour, the crystals were separated by filtration. The obtained crystals were washed with 18 ml of dioxane. 415.2 g of the filtrate containing the washing solution was concentrated to dryness, and isopropyl ether 230 was removed.
After stirring, the crystals were separated by filtration. The obtained crystals were dried to obtain 23.3 g of R-pyridazinone. Optical purity 9
8.9% e. e. And the yield was 26% (vs. (±) -pyridazinone).

【0014】実施例6(ラセミ化回収) 実施例2および5と同様に光学分割を行って得た濾液を
あわせた後(全量800g、ピリタジノン濃度1.23
wt%)濃縮し、ピリダジノン・L−酒石酸塩を濾別、
乾燥した。得たピリダジノン・L−酒石酸塩9.34g
(ピリダジノン含有率45.7wt%,光学純度51.
5%ee(S))に水76ml、濃塩酸4.38gを加
え、2時間加熱還流しラセミ化した。25〜30℃まで
冷却し、酢酸エチル10ml添加後、28%水酸化ナト
リウム水溶液12.3gを滴下、pH7.8に調整し
た。0〜5℃まで冷却し、30分撹拌後、濾別した。得
られた結晶は水11ml、酢酸エチル3mlで洗浄後、
乾燥し(±)−ピリダジノン3.65gを得た。化学純
度98.0wt%、光学純度はラセミ体であった。ピリ
ダジノン・L−酒石酸塩に対する収率は84%であっ
た。
Example 6 (racemic recovery) The filtrates obtained by optical resolution in the same manner as in Examples 2 and 5 were combined (total amount: 800 g, pyritadinone concentration: 1.23).
wt%), and concentrate the pyridazinone L-tartrate by filtration.
Dried. 9.34 g of the obtained pyridazinone L-tartrate
(Pyridazinone content 45.7 wt%, optical purity 51.
To 5% ee (S)), 76 ml of water and 4.38 g of concentrated hydrochloric acid were added, and the mixture was heated under reflux for 2 hours to be racemized. After cooling to 25 to 30 ° C. and adding 10 ml of ethyl acetate, 12.3 g of a 28% aqueous sodium hydroxide solution was added dropwise to adjust the pH to 7.8. After cooling to 0 to 5 ° C and stirring for 30 minutes, the mixture was filtered off. The obtained crystals were washed with 11 ml of water and 3 ml of ethyl acetate.
Drying yielded 3.65 g of (±) -pyridazinone. The chemical purity was 98.0 wt%, and the optical purity was a racemic form. The yield based on pyridazinone L-tartrate was 84%.

【0015】実施例7(ラセミ化回収したピリダジノン
での光学分割) 実施例6で回収したピリダジノン3.0g(化学純度9
8.0wt%,14.5mmol)に2−プロパノール
/酢酸エチル(35/65、体積比)87ml(6.0
l/M)、L−酒石酸2.61g(17.4mmol)
を加え、加熱溶解した。75℃で1時間撹拌後、ゆっく
り冷却した。48℃で結晶が析出するが、45〜50℃
で1時間撹拌後、20〜25℃までゆっくり冷却し、さ
らに1時間撹拌後、結晶を濾別した。得られた結晶は2
−プロパノール/酢酸エチル(35/65)7mlで洗
浄後、乾燥しピリダジノン・L−酒石酸塩4.41gを
得た。ピリダジノン・L−酒石酸塩のピリダジノン含有
率は46.9wt%、R−ピリダジノンの光学純度は2
9.5%e.e.であった。得られた結晶の収率は計算
により70%と求められた。ピリダジノンの光学純度
は、光学異性体分離用カラムを用いたHPLC法によっ
て測定した。測定条件は次の通りである。 カラム:CHIRALPAK AS 4.6mmφ×2
50mm(ダイセル化学工業株式会社) 溶離液:n−ヘキサン/エタノール=1/1(V/V) 流速 :1.0ml/min. 検出器:UV254nm カラム温度:40℃
Example 7 (optical resolution using racemized recovered pyridazinone) Pyridazinone 3.0 g recovered in Example 6 (chemical purity 9)
8.0 wt%, 14.5 mmol) and 87 ml of 2-propanol / ethyl acetate (35/65, volume ratio).
1 / M), 2.61 g (17.4 mmol) of L-tartaric acid
Was added and dissolved by heating. After stirring at 75 ° C. for 1 hour, the mixture was slowly cooled. Crystals precipitate at 48 ° C, but 45-50 ° C
After stirring for 1 hour, the mixture was slowly cooled to 20 to 25 ° C., and further stirred for 1 hour. The obtained crystal is 2
-Washed with 7 ml of propanol / ethyl acetate (35/65) and dried to obtain 4.41 g of pyridazinone L-tartrate. The pyridazinone content of pyridazinone L-tartrate is 46.9 wt%, and the optical purity of R-pyridazinone is 2
9.5% e. e. Met. The yield of the obtained crystals was calculated to be 70%. The optical purity of pyridazinone was measured by an HPLC method using a column for separating optical isomers. The measurement conditions are as follows. Column: CHIRALPAK AS 4.6mmφ × 2
Eluent: n-hexane / ethanol = 1/1 (V / V) Flow rate: 1.0 ml / min. Detector: UV254nm Column temperature: 40 ° C

【0016】[0016]

【発明の効果】本発明は、医薬品の中間体として有用な
光学活性ピリダジノンの製造、対掌体のラセミ化回収を
行い、工業的に有利な方法で安価に光学活性体を提供で
きる。具体的には従来法に比較し、高い光学純度、溶媒
量の大幅な低減、製造時間の大幅な短縮などを提供でき
る。
Industrial Applicability According to the present invention, an optically active pyridazinone useful as an intermediate of a pharmaceutical can be produced, and the enantiomer can be racemized and recovered, and an optically active substance can be provided at low cost by an industrially advantageous method. Specifically, compared to the conventional method, high optical purity, a large reduction in the amount of solvent, a significant reduction in the production time, and the like can be provided.

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 式[I] 【化1】 で表されるピリダジノンのラセミ体をL−またはD−酒
石酸を分割剤として低級アルコールとエステル類との混
合溶媒中で、光学分割することを特徴とする式[II] 【化2】 で表されるR−配置またはS−配置を有する光学活性ピ
リダジノンの製造方法。
1. A compound of the formula [I] Wherein the racemic pyridazinone represented by the formula is optically resolved in a mixed solvent of a lower alcohol and an ester using L- or D-tartaric acid as a resolving agent. A method for producing an optically active pyridazinone having an R-configuration or an S-configuration represented by the formula:
【請求項2】 式[I]で表されるピリダジノンのラセ
ミ体を有機溶媒中、L−またはD−酒石酸をピリダジノ
ンのラセミ体1モルに対し0.3〜1.8モル使用し分
割することを特徴とする式[II]で表されるR−配置ま
たはS−配置を有する光学活性ピリダジノンの製造方
法。
2. A method for resolving a racemic pyridazinone represented by the formula [I] in an organic solvent, wherein L- or D-tartaric acid is used in an amount of 0.3 to 1.8 mol per mol of racemic pyridazinone. A method for producing an optically active pyridazinone having an R-configuration or an S-configuration represented by the formula [II], characterized by the following:
【請求項3】 一般式[I]で表されるピリダジノンの
ラセミ体を低級アルコールとエステル類との混合溶媒中
で、L−またはD−酒石酸をピリダジノンのラセミ体1
モルに対し0.3〜1.8モル使用し分割することを特
徴とする式[II]で表されるR−配置またはS−配置を
有する光学活性ピリダジノンの製造方法。
3. A racemic pyridazinone represented by the formula [I], wherein L- or D-tartaric acid is racemic pyridazinone 1 in a mixed solvent of a lower alcohol and an ester.
A method for producing an optically active pyridazinone having an R-configuration or an S-configuration represented by the formula [II], characterized by using 0.3 to 1.8 moles per mole and dividing.
【請求項4】 光学分割され不要の式[II]で表される
R−配置またはS−配置を有する光学活性ピリダジノン
もしくはその酒石酸塩が過剰に含まれている系を酸また
は塩基の存在下、ラセミ化することを特徴とする式
[I]で表されるピリダジノンのラセミ体の回収方法。
4. A system containing an optically active pyridazinone having an R-configuration or an S-configuration represented by the formula [II], which is optically resolved and unnecessary, or a tartrate salt thereof is excessively contained in the presence of an acid or a base. A method for recovering a racemic pyridazinone represented by the formula [I], which comprises racemizing.
JP28295396A 1996-10-04 1996-10-04 Production of optically active pyridazinone derivative Withdrawn JPH10109977A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP28295396A JPH10109977A (en) 1996-10-04 1996-10-04 Production of optically active pyridazinone derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28295396A JPH10109977A (en) 1996-10-04 1996-10-04 Production of optically active pyridazinone derivative

Publications (1)

Publication Number Publication Date
JPH10109977A true JPH10109977A (en) 1998-04-28

Family

ID=17659268

Family Applications (1)

Application Number Title Priority Date Filing Date
JP28295396A Withdrawn JPH10109977A (en) 1996-10-04 1996-10-04 Production of optically active pyridazinone derivative

Country Status (1)

Country Link
JP (1) JPH10109977A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011007123A1 (en) 2009-07-14 2011-01-20 Cipla Limited Process for preparing levosimendan and intermediates for use in the process
CN103554032A (en) * 2013-11-12 2014-02-05 江苏正大清江制药有限公司 Preparation method of high-optical-purity (-)-6-(4-aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011007123A1 (en) 2009-07-14 2011-01-20 Cipla Limited Process for preparing levosimendan and intermediates for use in the process
US9000158B2 (en) 2009-07-14 2015-04-07 Cipla Limited Process for preparing levosimendan and intermediates for use in the process
CN103554032A (en) * 2013-11-12 2014-02-05 江苏正大清江制药有限公司 Preparation method of high-optical-purity (-)-6-(4-aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone

Similar Documents

Publication Publication Date Title
KR100879409B1 (en) Process for preparing s-bepotastine and intermediates used therein
US5677469A (en) Process for resolving chiral acids with 1-aminoindan-2-ols
JPH059164A (en) Production of optically active mandelonitrile derivative
JPH10109977A (en) Production of optically active pyridazinone derivative
JP3209041B2 (en) Optical resolving agent and process for producing optically active tetrahydrofurancarboxylic acids using the same
JP3484510B2 (en) Method for producing optically active carboxylic acid
JPH11228512A (en) Production of d-alloisoleucine and intermediate therefor
JP3665976B2 (en) Optical resolving agent and process for producing optically active N-tert-butyl-2-piperazinecarboxamide using the same
JP2830364B2 (en) Method for producing optically active 1-benzyl-3-hydroxypyrrolidine
JP2671572B2 (en) Process for producing optically active 1- (p-chlorophenyl) -1- (2-pyridyl) -3-dimethylaminopropane
JP3157118B2 (en) Optical resolution method of piperidine derivative using acylamino acid
JP3284608B2 (en) Method for producing optically active 1-phenylethylamine derivative
JP3304419B2 (en) Method for producing optically active 1- (4-halogenophenyl) ethylamine
JP4109446B2 (en) Process for producing pure trans-2-[(α-methylbenzyl) amino] cyclopentanol as a diastereoisomer
JP3032547B2 (en) Resolution method of optically active 2-methylpiperazine
JP3284605B2 (en) Method for producing optically active 1- (1-naphthyl) ethylamine
JP4104319B2 (en) Process for producing optically active 2-hydroxy-3-nitropropionic acid
JPH09124595A (en) Reagent for optical resolution and production of optically active 3-aminopyrrolidine derivative
JPH10101629A (en) Production of optically active butyric acid derivative
JP2551216B2 (en) Process for producing optically active 1- (p-chlorophenyl) -1- (2-pyridyl) -3-dimethylaminopropane
JP2002193933A (en) Production method of optically active piperidine derivative and its acid salt
JP2001328971A (en) Method for purifying amino acid amide
JPS6323824A (en) Optical resolution and racemization of amine having acidic alpha-hydrogen
JP2819800B2 (en) Method for producing optically active 1- (p-chlorophenyl) -1- (2-pyridyl) -3-dimethylaminopropane
JP2003034683A (en) Production method for optically active 2- methylpiperazine

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20040106